|
1
|
Wagner KH, Shiels RG, Lang CA, Seyed Khoei
N and Bulmer AC: Diagnostic criteria and contributors to Gilbert's
syndrome. Crit Rev Clin Lab Sci. 55:129–139. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sieg A, Arab L, Schlierf G, Stiehl A and
Kommerell B: Prevalence of Gilbert's syndrome in Germany. Dtsch Med
Wochenschr. 112:1206–1208. 1987.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
3
|
Maruo Y, Nakahara S, Yanagi T, Nomura A,
Mimura Y, Matsui K, Sato H and Takeuchi Y: Genotype of UGT1A1 and
phenotype correlation between Crigler-Najjar syndrome type II and
Gilbert syndrome. J Gastroenterol Hepatol. 31:403–408.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
D'Angelo R, Rinaldi C, Donato L, Nicocia G
and Sidoti A: The combination of new missense mutation with
[A(TA)7TAA] dinucleotide repeat in UGT1A1 gene promoter causes
Gilbert's syndrome. Ann Clin Lab Sci. 45:202–205. 2015.PubMed/NCBI
|
|
5
|
Fretzayas A, Moustaki M, Liapi O and
Karpathios T: Gilbert syndrome. Eur J Pediatr. 171:11–15.
2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Berrueco R, Alonso-Saladrigues A,
Martorell-Sampol L, Catala-Temprano A, Ruiz-Llobet A, Toll T,
Torrebadell M, Naudo M, Camos M and Rives S: Outcome and toxicities
associated to chemotherapy in children with acute lymphoblastic
leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational
screening. Pediatr Blood Cancer. 62:1195–1201. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Butorac Ahel I, Baraba Dekanic K,
Palcevski G and Roganovic J: An infant with unusually high
unconjugated hyperbilirubinemia due to coexistence of hereditary
spherocytosis and gilbert syndrome. J Pediatr Hematol Oncol.
40:e127–e128. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zahedpasha Y, Ahmadpour M, Niaki HA and
Alaee E: Relation between neonatal icter and gilbert syndrome in
gloucose-6-phosphate dehydrogenase deficient subjects. J Clin Diagn
Res. 8:63–65. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tzetis M, Kanavakis E, Tsezou A, Ladis V,
Pateraki E, Georgakopoulou T, Kavazarakis E, Maragoudaki E,
Karpathios T and Kitsiou-Tzeli S: Gilbert syndrome associated with
beta-thalassemia. Pediatr Hematol Oncol. 18:477–484.
2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ha VH, Jupp J and Tsang RY: Oncology drug
dosing in gilbert syndrome associated with UGT1A1: A summary of the
literature. Pharmacotherapy. 37:956–972. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fang X, Zaman MH, Guo X, Ding H, Xie C,
Zhang X and Deng GM: Role of hepatic deposited immunoglobulin G in
the pathogenesis of liver damage in systemic lupus erythematosus.
Front Immunol. 9(1457)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chowdhary VR, Crowson CS, Poterucha JJ and
Moder KG: Liver involvement in systemic lupus erythematosus: Case
review of 40 patients. J Rheumatol. 35:2159–2164. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vitek L, Muchova L, Jancova E, Pesickova
S, Tegzova D, Peterova V, Pavelka K, Tesar V and Schwertner H:
Association of systemic lupus erythematosus with low serum
bilirubin levels. Scand J Rheumatol. 39:480–484. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Petri M, Orbai AM, Alarcon GS, Gordon C,
Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O,
et al: Derivation and validation of the Systemic Lupus
International Collaborating Clinics classification criteria for
systemic lupus erythematosus. Arthritis Rheum. 64:2677–2686.
2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ehmer U, Kalthoff S, Fakundiny B, Pabst B,
Freiberg N, Naumann R, Manns MP and Strassburg CP: Gilbert syndrome
redefined: A complex genetic haplotype influences the regulation of
glucuronidation. Hepatology. 55:1912–1921. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bombardier C, Gladman DD, Urowitz MB,
Caron D and Chang CH: Derivation of the SLEDAI: A disease activity
index for lupus patients. The Committee on Prognosis Studies in
SLE. Arthritis Rheum. 35:630–640. 1992.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gladman DD, Ibañez D and Urowitz MB:
Systemic lupus erythematosus disease activity index 2000. J
Rheumatol. 29:288–291. 2002.PubMed/NCBI
|
|
18
|
Kumar D, Parakh A and Sharma S: Gilbert
syndrome increasing unconjugated hyperbilirubinemia in a child with
hereditary spherocytosis. J Pediatr Hematol Oncol. 34:54–56.
2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bale G, Avanthi US, Padaki NR, Sharma M,
Duvvur NR and Vishnubhotla VRK: Incidence and risk of gallstone
disease in gilbert's syndrome patients in Indian population. J Clin
Exp Hepatol. 8:362–366. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li XX, Shi J, Huang ZD, Shao YQ, Nie N,
Zhang J, Ge ML, Huang JB and Zheng YZ: Clinical characteristics and
gene mutations of gilbert syndrome complicated with
myeloproliferative neoplasm. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
25:567–571. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
21
|
Canu G, Minucci A, Zuppi C and Capoluongo
E: Gilbert and crigler najjar syndromes: An update of the
UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database.
Blood Cells Mol Dis. 50:273–280. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mendez L, Lagoa M, Quiroga T, Margozzini
P, Azocar L, Molina HR, Vera A, Villarroel L, Arrese M, Hampe J, et
al: Prevalence of Gilbert syndrome and its genetic determinants in
Chile. Rev Med Chil. 141:1266–1274. 2013.PubMed/NCBI View Article : Google Scholar : (In Spanish).
|
|
23
|
Gwee KA, Koay ES and Kang JY: The
prevalence of isolated unconjugated hyperbilirubinaemia (Gilbert's
syndrome) in subjects attending a health screening programme in
Singapore. Singapore Med J. 33:588–589. 1992.PubMed/NCBI
|
|
24
|
Hemmati F, Saki F, Saki N and Haghighat M:
Gilbert syndrome in Iran, fars province. Ann Saudi Med.
30(84)2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bosma PJ, Chowdhury JR, Bakker C, Gantla
S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude
Elferink RP, et al: The genetic basis of the reduced expression of
bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N
Engl J Med. 333:1171–1175. 1995.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sato H, Adachi Y and Koiwai O: The genetic
basis of Gilbert's syndrome. Lancet. 347:557–558. 1996.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Burchell B and Hume R: Molecular genetic
basis of Gilbert's syndrome. J Gastroenterol Hepatol. 14:960–966.
1999.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hsieh TY, Shiu TY, Huang SM, Lin HH, Lee
TC, Chen PJ, Chu HC, Chang WK, Jeng KS, Lai MM and Chao YC:
Molecular pathogenesis of Gilbert's syndrome: Decreased
TATA-binding protein binding affinity of UGT1A1 gene promoter.
Pharmacogenet Genomics. 17:229–236. 2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Radoi VE, Ursu RI, Poenaru E, Arsene C,
Bohiltea CL and Bohiltea R: Frequency of the UGT1A1*28 polymorphism
in a Romanian Cohort of gilbert syndrome individuals. J
Gastrointestin Liver Dis. 26:25–28. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sun L, Li M, Zhang L, Teng X, Chen X, Zhou
X, Ma Z, Qi L and Wang P: Differences in UGT1A1 gene mutations and
pathological liver changes between Chinese patients with Gilbert
syndrome and Crigler-Najjar syndrome type II. Medicine (Baltimore).
96(e8620)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nakagawa T, Mure T, Yusoff S, Ono E,
Kusuma Harahap IS, Morikawa S, Morioka I, Takeshima Y, Nishio H and
Matsuo M: A homozygous mutation in UGT1A1 exon 5 may be responsible
for persistent hyperbilirubinemia in a Japanese girl with Gilbert's
syndrome. Kobe J Med Sci. 57:E26–E31. 2011.PubMed/NCBI
|
|
32
|
Court MH, Duan SX, von Moltke LL,
Greenblatt DJ, Patten CJ, Miners JO and Mackenzie PI:
Interindividual variability in acetaminophen glucuronidation by
human liver microsomes: Identification of relevant acetaminophen
UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther.
299:998–1006. 2001.PubMed/NCBI
|
|
33
|
Gelotte CK, Auiler JF, Lynch JM, Temple AR
and Slattery JT: Disposition of acetaminophen at 4, 6, and 8 g/day
for 3 days in healthy young adults. Clin Pharmacol Ther.
81:840–848. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lester R and Schmid R: Bilirubin
Metabolism. N Engl J Med. 270:779–786. 1964.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Watchko JF and Tiribelli C:
Bilirubin-induced neurologic damage-mechanisms and management
approaches. N Engl J Med. 369:2021–2030. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Vitek L, Jirsa M, Brodanova M, Kalab M,
Marecek Z, Danzig V, Novotny L and Kotal P: Gilbert syndrome and
ischemic heart disease: A protective effect of elevated bilirubin
levels. Atherosclerosis. 160:449–456. 2002.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ilzecka J and Stelmasiak Z: Serum
bilirubin concentration in patients with amyotrophic lateral
sclerosis. Clin Neurol Neurosurg. 105:237–240. 2003.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yuce S, Cure E, Cicek Y, Cumhur Cure M,
Yilmaz A and Kizilkaya B: Evaluation of aortic stiffness in Gilbert
syndrome patients: A protective effect of elevated bilirubin
levels. Turk Kardiyol Dern Ars. 43:599–606. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
McCarty MF: ‘Iatrogenic Gilbert
syndrome’-a strategy for reducing vascular and cancer risk by
increasing plasma unconjugated bilirubin. Med Hypotheses.
69:974–994. 2007.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Maruhashi T, Soga J, Fujimura N, Idei N,
Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Kihara Y, Chayama K,
et al: Hyperbilirubinemia, augmentation of endothelial function,
and decrease in oxidative stress in Gilbert syndrome. Circulation.
126:598–603. 2012.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Duguay Y, McGrath M, Lépine J, Gagné JF,
Hankinson SE, Colditz GA, Hunter DJ, Plante M, Têtu B, Bélanger A,
et al: The functional UGT1A1 promoter polymorphism decreases
endometrial cancer risk. Cancer Res. 64:1202–1207. 2004.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Strassburg CP: Hyperbilirubinemia
syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and
Rotor syndrome). Best Pract Res Clin Gastroenterol. 24:555–571.
2010.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ribrag V, Koscielny S, Casasnovas O,
Cazeneuve C, Brice P, Morschhauser F, Gabarre J, Stamatoullas A,
Lenoir G and Salles G: Groupe d'Etude des Lymphomes agressifs
group, Laboratoire de Génétique et de recherche translationnelle,
Institut Gustave Roussy. Pharmacogenetic study in Hodgkin lymphomas
reveals the impact of UGT1A1 polymorphisms on patient prognosis.
Blood. 113:3307–3313. 2009.PubMed/NCBI View Article : Google Scholar
|
|
44
|
dos Santos BH, de R Almeida CM and Skare
TL: Systemic Lupus Erythematosus activity and serum bilirubins.
Acta Reumatol Port. 38:242–246. 2013.PubMed/NCBI
|
|
45
|
Lozovoy MA, Simao AN, Panis C, Rotter MA,
Reiche EM, Morimoto HK, Lavado E, Cecchini R and Dichi I: Oxidative
stress is associated with liver damage, inflammatory status, and
corticosteroid therapy in patients with systemic lupus
erythematosus. Lupus. 20:1250–1259. 2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Jamwal M, Aggarwal A, Kumar V, Sharma P,
Sachdeva MU, Bansal D, Malhotra P and Das R: Disease-modifying
influences of coexistent G6PD-deficiency, Gilbert syndrome and
deletional alpha thalassemia in hereditary spherocytosis: A report
of three cases. Clin Chim Acta. 458:51–54. 2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Singer S, Pilpel N and Pinhas-Hamiel O:
Gilbert syndrome in patients with type 1 diabetes-prevalence,
glycemic control, and microalbuminuria. Pediatr Diabetes.
18:803–807. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Moyer AM, Skierka JM, Kotzer KE, Kluge ML,
Black JL and Baudhuin LM: Clinical UGT1A1 genetic analysis in
pediatric patients: Experience of a reference laboratory. Mol Diagn
Ther. 21:327–335. 2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Aiso M, Yagi M, Tanaka A, Miura K, Miura
R, Arizumi T, Takamori Y, Nakahara S, Maruo Y and Takikawa H:
Gilbert Syndrome with concomitant hereditary spherocytosis
presenting with moderate unconjugated hyperbilirubinemia. Intern
Med. 56:661–664. 2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Pasha YZ, Kacho MA, Niaki HA, Tarighati M
and Alaee E: The association between prolonged jaundice and TATA
box dinucleotide repeats in Gilbert's syndrome. J Clin Diagn Res.
11:GC05–GC07. 2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Haddad F, Trabelsi N, Chaouch L, Darragi
I, Oueslati M, Boudriga I, Chaouachi D, El-Borgi W, Hafsia R, Abbes
S and Ouragini H: Homozygous mutation on the β-globin
polyadenylation signal in a Tunisian patient with β-Thalassemia
intermedia and coinheritance of Gilbert's syndrome. Hemoglobin.
41:147–150. 2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Qian JD, Hou FQ, Wang TL, Shao C and Wang
GQ: Gilbert syndrome combined with prolonged jaundice caused by
contrast agent: Case report. World J Gastroenterol. 24:1486–1490.
2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Kamal S, Abdelhakam S, Ghoraba D, Massoud
Y, Aziz KA, Hassan H, Hafez T and Abdel Sallam A: The frequency,
clinical course, and health related quality of life in adults with
Gilbert's syndrome: A longitudinal study. BMC Gastroenterol.
19(22)2019.PubMed/NCBI View Article : Google Scholar
|
